Global Recombinant Cytokines Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 2.78 Million |
 Market Size (Forecast Year) |
USD 4.20 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球重组细胞因子市场，按类型（干扰素、重组人粒细胞集落刺激素、促红细胞生成素 (EPO)、重组人血小板生成素、其他）、应用（乙型肝炎、丙型肝炎、多发性硬化症、肿瘤治疗、伤口愈合、其他）、最终用户（医院、家庭护理、专科诊所、其他）划分 - 行业趋势和预测到 2030 年。
重组细胞因子市场分析和规模
全球范围内正在进行的基因组研究是推动重组细胞因子市场增长的主要因素之一。制药公司为改进产品而进行的研发活动增加，以及政府对支持癌症研究和相关计划的投资激增，加速了市场的增长。商业渠道的发展以及人口中癌症、肝炎和硬化症等各种慢性疾病的患病率上升进一步影响了市场。
Data Bridge Market Research 分析称，全球重组细胞因子市场在 2022 年为 278 万美元，预计到 2030 年将达到 420 万美元，预测期内复合年增长率可能达到 5.4%。由于对更好的诊断和治疗方法的需求不断增长，“干扰素”在全球重组细胞因子市场类型细分市场中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按类型（干扰素、重组人粒细胞集落刺激素、促红细胞生成素 (EPO)、重组人血小板生成素、其他）、应用（乙型肝炎、丙型肝炎、多发性硬化症、肿瘤治疗、伤口愈合、其他）、最终用户（医院、家庭护理、专科诊所、其他） |
|
覆盖国家 |
（美国、加拿大、墨西哥、秘鲁、巴西、阿根廷、南美洲其他地区、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、越南、亚太地区其他地区、南非、沙特阿拉伯、阿联酋、科威特、以色列、埃及、中东和非洲其他地区 |
|
涵盖的市场参与者 |
Thermo Fisher Scientific Inc. (United States), AnkeBio Co., Ltd (China), EMD Serono, Inc. (United States), Ferring B.V. (Switzerland), Ipsen Pharma (France), Novo Nordisk A/S (Denmark), Pfizer (United States), Teva Pharmaceutical Industries Ltd (Israel), Eurofins DiscoverX Corporation (United States), and Merck KGaA (Germany) |
|
Market Opportunities |
|
Market Definition
Recombinant cytokines refer to the drug type that are specifically designed for enhancing immunity either by achieving generalized immunostimulation or stimulating specific immune cells. These proteins have enhanced the treatment options for various diseases, and are widely associated with novel toxicities.
Global Recombinant Cytokines Market Dynamics
Drivers
- Growing focus on immunotherapy
Immunotherapy has gained prominence in the treatment of cancer and other diseases. Cytokines are integral components of immunotherapy, and the increasing interest in this treatment approach is boosting the market for recombinant cytokines.
- Biotechnology and Pharmaceutical Collaborations
Collaborations between biotechnology and pharmaceutical companies are driving the development and commercialization of recombinant cytokines, expanding their market presence.
Opportunities
- Rising demand for immunotherapies
The increasing use of cytokines, such as Interferons and Interleukins, in immunotherapies for cancer and autoimmune diseases presents a significant growth opportunity. Recombinant cytokines are essential components in these therapies.
- Growth in emerging markets
The expanding healthcare infrastructure and increasing healthcare expenditure in emerging markets provide a substantial growth opportunity for recombination cytokines manufacturers to tap into new consumer bases.
Restraints/Challenges
- High development costs
Developing recombinant cytokines for therapeutic purposes can be expensive due to the need for extensive research, clinical trials, and manufacturing processes, which can deter smaller companies from entering the market.
- Limited understanding of immune response
Despite advancements, there is still a limited understanding of the complex immune response, leading to uncertainties in designing effective cytokine therapies and potential side effects.
This recombinant cytokines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global recombinant cytokines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Recombinant Cytokines Market Scope
Global recombinant cytokines market is categorized into three notable segments which are based on the basis of type, application and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Interferon
- Recombinant Human Granulocyte Colony-Stimulating
Application
- Hepatitis B
- Hepatitis C
- Multiple Sclerosis
- Tumor Therapy
- Wound Healing
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Global Recombinant Cytokines Market Regional Analysis/Insights
The recombinant cytokines market is analyzed and market size information is provided by country, type, application and end-users as referenced above.
The countries covered in the global recombinant cytokines market report are U.S., Canada and Mexico, Peru, Brazil, Argentina and rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.
North America is expected to dominate the recombinant cytokines market due to the presence of advanced healthcare infrastructure within the region. Asia-Pacific is expected to witness high growth during the forecast period of 2023 to 2030 because of the increase in research and development in the region.
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球重组细胞因子市场份额分析
重组细胞因子市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对重组细胞因子市场的关注有关
重组细胞因子市场的一些主要参与者包括：
- 赛默飞世尔科技公司（美国）
- 安科生物股份有限公司 (中国)
- EMD Serono, Inc.（美国）
- Ferring BV（荷兰）
- 益普生制药（法国）
- 诺和诺德公司（丹麦）
- 辉瑞（美国）
- 梯瓦制药工业有限公司 (以色列)
- Eurofins DiscoverX Corporation（美国）
- 默克集团（德国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
